LRP and senile plaques in Alzheimer's disease: colocalization with apolipoprotein E and with activated astrocytes (Q48549023)

12 February 2018

title

LRP and senile plaques in Alzheimer's disease: colocalization with apolipoprotein E and with activated astrocytes (English)

1 reference

12 February 2018

0 references

0 references

7

Bradley T Hyman

1 reference

12 February 2018

Katrin Arélin

1

1 reference

12 February 2018

Ayae Kinoshita

2

1 reference

12 February 2018

Christa M Whelan

3

1 reference

12 February 2018

Michael C Irizarry

4

1 reference

12 February 2018

G William Rebeck

5

1 reference

12 February 2018

Dudley K Strickland

6

1 reference

12 February 2018

publication date

1 July 2002

1 reference

12 February 2018

published in

Molecular Brain Research

1 reference

12 February 2018

volume

104

1 reference

12 February 2018

issue

1

1 reference

12 February 2018

page(s)

38-46

1 reference

12 February 2018

Immunochemical identification of the serine protease inhibitor alpha 1-antichymotrypsin in the brain amyloid deposits of Alzheimer's disease

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2802%2900203-6

7 January 2021

Scavenging of Alzheimer's amyloid beta-protein by microglia in culture.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2802%2900203-6

7 January 2021

Lack of apolipoprotein E dramatically reduces amyloid beta-peptide deposition.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2802%2900203-6

7 January 2021

Interleukin-6 and α-2-macroglobulin indicate an acute-phase state in Alzheimer's disease cortices

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2802%2900203-6

7 January 2021

Apolipoprotein E isoform-specific reduction of extracellular amyloid in neuronal cultures

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2802%2900203-6

7 January 2021

Modulation of the alpha 2 macroglobulin receptor/low density lipoprotein receptor related protein by interferon-gamma in human astroglial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2802%2900203-6

7 January 2021

Fibrillogenesis in Alzheimer's disease of amyloid beta peptides and apolipoprotein E.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2802%2900203-6

7 January 2021

Quantitation of apoE domains in Alzheimer disease brain suggests a role for apoE in Abeta aggregation

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2802%2900203-6

7 January 2021

Immunoglobulins and complement factors in senile plaques. An immunoperoxidase study.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2802%2900203-6

7 January 2021

Apolipoprotein E is a kinetic but not a thermodynamic inhibitor of amyloid formation: implications for the pathogenesis and treatment of Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2802%2900203-6

7 January 2021

Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2802%2900203-6

7 January 2021

Clinical and pathological correlates of apolipoprotein E ?4 in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2802%2900203-6

7 January 2021

Role of the low-density lipoprotein receptor-related protein in beta-amyloid metabolism and Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2802%2900203-6

7 January 2021

Apolipoprotein E affects the amount, form, and anatomical distribution of amyloid beta-peptide deposition in homozygous APP(V717F) transgenic mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2802%2900203-6

7 January 2021

Modulation of A beta deposition in APP transgenic mice by an apolipoprotein E null background.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2802%2900203-6

7 January 2021

Abeta deposition is associated with neuropil changes, but not with overt neuronal loss in the human amyloid precursor protein V717F (PDAPP) transgenic mouse.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2802%2900203-6

7 January 2021

Isoform-specific effect of apolipoprotein E on cell survival and beta-amyloid-induced toxicity in rat hippocampal pyramidal neuronal cultures.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2802%2900203-6

7 January 2021

Apolipoprotein E receptors mediate the effects of beta-amyloid on astrocyte cultures

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2802%2900203-6

7 January 2021

Apolipoprotein E and apolipoprotein E receptors modulate A beta-induced glial neuroinflammatory responses

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2802%2900203-6

7 January 2021

Apolipoprotein E modulates glial activation and the endogenous central nervous system inflammatory response.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2802%2900203-6

7 January 2021

Amyloid-associated proteins α1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer β-protein into filaments

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2802%2900203-6

7 January 2021

Apolipoprotein E exhibits isoform-specific promotion of lipid efflux from astrocytes and neurons in culture

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2802%2900203-6

7 January 2021

Distribution of the alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein in human tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2802%2900203-6

7 January 2021

Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2802%2900203-6

7 January 2021

Microglial cells internalize aggregates of the Alzheimer's disease amyloid beta-protein via a scavenger receptor.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2802%2900203-6

7 January 2021

Alpha2-macroglobulin enhances the clearance of endogenous soluble beta-amyloid peptide via low-density lipoprotein receptor-related protein in cortical neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2802%2900203-6

7 January 2021

Elevation of LDL receptor-related protein levels via ligand interactions in Alzheimer disease and in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2802%2900203-6

7 January 2021

Soluble low density lipoprotein receptor-related protein (LRP) circulates in human plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2802%2900203-6

7 January 2021

Multiple, diverse senile plaque-associated proteins are ligands of an apolipoprotein E receptor, the alpha 2-macroglobulin receptor/low-density-lipoprotein receptor-related protein.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2802%2900203-6

7 January 2021

Apolipoprotein E in sporadic Alzheimer's disease: allelic variation and receptor interactions

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2802%2900203-6

7 January 2021

Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2802%2900203-6

7 January 2021

Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2802%2900203-6

7 January 2021

Alpha 1-trypsin immunoreactivity in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2802%2900203-6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2802%2900203-6

7 January 2021

Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2802%2900203-6

7 January 2021

The subunits of alpha2-macroglobulin receptor/low density lipoprotein receptor-related protein, native and transformed alpha2-macroglobulin and interleukin 6 in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2802%2900203-6

7 January 2021

Immunohistochemical study of alpha 2 macroglobulin receptor in Alzheimer and control postmortem human brain

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2802%2900203-6

7 January 2021

alpha 2-Macroglobulin expression in neuritic-type plaques in patients with Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2802%2900203-6

7 January 2021

Apolipoprotein E: a pathological chaperone protein in patients with cerebral and systemic amyloid

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2802%2900203-6

7 January 2021

Apolipoprotein E promotes the binding and uptake of beta-amyloid into Chinese hamster ovary cells in an isoform-specific manner

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2802%2900203-6

7 January 2021

10.1016/S0169-328X(02)00203-6

Identifiers

DOI

1 reference

12 February 2018

1 reference

12 February 2018